Goal Management Training plus Attention Training for Cognition

Phase-Based Progress Estimates
1
Effectiveness
1
Safety
North Florida/South Georgia Veterans Health System, Gainesville, FL, Gainesville, FL
Cognition+4 More
Goal Management Training plus Attention Training - Behavioral
Eligibility
18 - 65
All Sexes
What conditions do you have?
Select

Study Summary

This trial will test a new combined strategy training to help improve cognitive function in veterans with mild traumatic brain injury and post-traumatic stress disorder. The goal of Goal Management Training plus Attention Training is to help veterans improve their cognition. This treatment has been previously approved by the FDA for a different condition and is now being used to help veterans improve their cognition.

Eligible Conditions

  • Cognition
  • Injuries, Brain
  • Intervention
  • Post Traumatic Stress Disorder (PTSD)

Treatment Effectiveness

Effectiveness Progress

1 of 3

Study Objectives

1 Primary · 5 Secondary · Reporting Duration: pre-intervention, post, 6-month and 1-year follow-up

pre-intervention, post, 6-month and 1-year follow-up
Change in the Composite Executive score of the Executive Abilities: Measures and Instruments for Neurobehavioral Evaluation and Research
week 1, week 11
Change in the Test of Grocery Shopping Skills
Week 59
Change in Attention Network Task
Change in Traumatic Brain Injury-Quality of Life, Participation Ability and Satisfaction short-form
Change in the Unstructured Task of the Executive Abilities: Measures and Instruments for Neurobehavioral Evaluation and Research
Change in the attention index of the Repeatable Battery for the Assessment of Neuropsychological Status

Trial Safety

Safety Progress

1 of 3

Trial Design

3 Treatment Groups

Inpatient GMT plus Attention Training
1 of 3
Telehealth GMT plus Attention Training
1 of 3
Brain Health Workshop
1 of 3
Experimental Treatment
Non-Treatment Group

63 Total Participants · 3 Treatment Groups

Primary Treatment: Goal Management Training plus Attention Training · Has Placebo Group · N/A

Inpatient GMT plus Attention Training
Behavioral
Experimental Group · 1 Intervention: Goal Management Training plus Attention Training · Intervention Types: Behavioral
Telehealth GMT plus Attention Training
Behavioral
Experimental Group · 1 Intervention: Goal Management Training plus Attention Training · Intervention Types: Behavioral
Brain Health Workshop
Behavioral
PlaceboComparator Group · 1 Intervention: Brain Health Workshop and National Geographic Movies · Intervention Types: Behavioral

Trial Logistics

Trial Timeline

Approximate Timeline
Screening: ~3 weeks
Treatment: Varies
Reporting: pre-intervention, post, 6-month and 1-year follow-up
Closest Location: North Florida/South Georgia Veterans Health System, Gainesville, FL · Gainesville, FL
Photo of Gainesville 1Photo of Gainesville 2Photo of florida 3
2009First Recorded Clinical Trial
1 TrialsResearching Cognition
36 CompletedClinical Trials

Who is running the clinical trial?

VA Office of Research and DevelopmentLead Sponsor
1,462 Previous Clinical Trials
2,749,158 Total Patients Enrolled
1 Trials studying Cognition
150 Patients Enrolled for Cognition
Julia K. Waid-Ebbs, PhDPrincipal InvestigatorNorth Florida/South Georgia Veterans Health System, Gainesville, FL
3 Previous Clinical Trials
121 Total Patients Enrolled

Eligibility Criteria

Age 18 - 65 · All Participants · 5 Total Inclusion Criteria

Mark “yes” if the following statements are true for you:
You have a history of a concussion in the past 6 months.
You have a deficit in attention.

About The Reviewer

Michael Gill preview

Michael Gill - B. Sc.

First Published: October 9th, 2021

Last Reviewed: August 12th, 2022

Michael Gill holds a Bachelors of Science in Integrated Science and Mathematics from McMaster University. During his degree he devoted considerable time modeling the pharmacodynamics of promising drug candidates. Since then, he has leveraged this knowledge of the investigational new drug ecosystem to help his father navigate clinical trials for multiple myeloma, an experience which prompted him to co-found Power Life Sciences: a company that helps patients access randomized controlled trials.